A bad 30-year US bond sale just occurred. Really bad. While the yield on the $22 billion offering was lower than last month, it was higher than expected. And demand was generaly weak, particularly from foreign buyers. We are going to have to continue to issue massive amounts of new and rollover debt. The uncertainty about our economy and our trade policy are not going to help in selling that at the kind of rates we want to sell it at. After-market rates haven’t gone up but only because the sell-off in stocks continues and some are going to the perceived safety of bonds. I say perceived because as inflation revives, interest rates will rise and people will have loses on those bonds.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
The Anti-Strib, March 23, 2025
March 23, 2025
The Anti-Strib, March 23, 2025
An outrageous op-ed by our former health commissioner.
Commentary
More on Federal Government Departments
March 22, 2025
More on Federal Government Departments
A little more analysis and history on this very timely topic.
Commentary
The Anti-Strib, March 21 & 22
March 22, 2025
The Anti-Strib, March 21 & 22
Just another day of Trump bashing and Dem protecting by the Strib.